Important factors for pain during photodynamic therapy for actinic keratosis

Acta Dermato-Venereologica

Volumn 86, Issue 5, 2006, Pages 404-408

  Sandberg, Carin ^a   Stenquist, Bo ^a   Rosdahl, Inger ^b   Ros, Anne Marie ^c   Synnerstad, Ingrid ^b   Karlsson, Maria ^c   Gudmundson, Fredrik ^d   Ericson, Marica B ^a   Larkö, Olle ^a   Wennberg, Ann Marie ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Actinic keratosis; Aminolaevulinic acid; Capsaicin; Pain; PDT

Indexed keywords

AMINOLEVULINIC ACID; CAPSAICIN; CAPSINA;

ACTINIC KERATOSIS; ADULT; AGED; ANALGESIA; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; SKIN DEFECT; SKIN REDNESS; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; CAPSAICIN; COLOR; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS;

EID: 33749000269     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0098     Document Type: Article

References (31)

1. Morton CA. Photodynamic therapy for nonmelanoma skin cancer - and more? Arch Dermatol 2004; 140: 116-120.
2. Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls. J Dermatolog Treat 2003; 14 (suppl 3): 23-26.
3. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567.
4. Szeimies RM, Karrer S, Backer H. Therapieoptionen bei epithelialen Hauttumoren Aktinische Keratosen, Morbus Bowen, spinozelluläres Karzinom und Basalzellkarzinom. Hautarzt 2005; 56: 430-440.
5. Grapengiesser S, Ericson M, Gudmundsson F, Larkö O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
6. Wang I. Photodynamic therapy and laser-based diagnostic studies of malignant tumors. PhD Thesis. Lund: Lund University, 1999.
7. Chamberlain AJ, Kurwa HA. Photodynamic therapy: is it a valuable treatment option for actinic keratoses? Am J Clin Dermatol 2003; 4: 149-155.
8. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-262.
9. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros A-M, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204-1212.
10. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-292.
11. Brennan MJ, Cantrill RC. Delta-aminolaevulinic acid and amino acid neurotransmitters. Mol Cell Biochem 1981; 38: 49-58.
12. Orenstein A, Kostenich G, Tsur H, Kogan L, Malik Z. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. Cancer Letters 1995; 93: 227-232.
13. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003; 88: 1772-1779.
14. Casas A, Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med Chem Anti-Cane Agents 2002; 2: 465-475.
15. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413; quiz 414-416.
16. Berg K, Anholt H, Bech O, Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br J Cancer 1996; 74: 688-697.
17. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004; 150: 337-340.
18. Wallengren J, Håkanson R. Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin. Br J Dermatol 1992; 126: 111-117.
19. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999; 81: 135-145.
20. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328: 991.
21. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003; 19: 134-141.
22. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 1997; 13: 181-185.
23. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-772.
24. Fusco BM, Giacovazzo M. Peppers and pain. The promise of capsaicin. Drugs 1997; 53: 909-914.
25. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989; 21: 265-270.
26. Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986; 38: 179-226.
27. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 1995; 7: 317-328.
28. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003; 139: 1173-1177.
29. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatologic Surgery 2004; 30: 63-66.
30. Curnow A, Haller JC, Bown SG. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon - comparison of continuous and fractionated light regimes. J Photochem Photobiol B - Biol 2000; 58: 149-155.
31. Muller S, Walt H, Dobler-Girdziunaite D, Fiedler D, Haller U. Enhanced photodynamic effects using fractionated laser light. J Photochem Photobiol B 1998; 42: 67-70.